| Risk factors for Pseudomonas VAP |
Cases (n=38) |
Controls (n=38) |
p value |
| Age, years |
54.03 ± 18.82 |
55.9 ± 17.62 |
0,65 |
| Female Sex (%) |
9 (23,68) |
10 (26,32) |
0,08 |
| Patients baseline conditions (%) |
|
|
|
| Alcohol |
3 (7,89) |
2 (5,26) |
0,64 |
| Drugs abuse |
1 (2,63) |
1 |
1 |
| Cirrhosis |
2 (5,26) |
0 |
0,09 |
| Diabetes |
6 (15,79) |
3 (7,89) |
0,28 |
| COPD |
10 (26,32) |
5 (13,16) |
0,15 |
| Chronic steroid therapy (%) |
7 (18,42) |
4 (10,53) |
0,32 |
| HIV |
0 |
1 (2,63) |
0,24 |
| Surgery (%) |
20 (52,63) |
22 (57,89) |
0,64 |
| Charlson Comorbidity Index |
2,10 ± 2,34 |
1,47 ± 2,12 |
0,04 |
| Previous 6 months hospitalisation (%) |
17 (44,74) |
5 (13,16) |
0,03 |
| Provenance from other wards (%) |
25 (65,79) |
12 (31,58) |
<0,01 |
| Predicted mortality by SAPS |
|
|
0,54 |
| SAPS II |
46,8 ± 16,95 |
46,65 ± 14,09 |
|
| SAPS III |
59,87 ± 24,83 |
66 ± 15,04 |
|
| Admission pathology (%) |
|
|
|
| Neurologic |
6 (15,79) |
13 (34,21) |
|
| Cardiocirculatory |
10 (26,32) |
2 (5,26) |
0.04 |
| Respiratory |
7 (18,42) |
5 (13,16) |
|
| Trauma |
12 (31,58) |
18 (47,37) |
|
| Central venous catheter (%) |
36 (94,74) |
36 (94,74) |
0,64 |
| Number of catheter-days |
10,31 ± 10,41 |
7 ,35 ± 7,71 |
0,19 |
| Dialysis (%) |
3 (7,89) |
3 (7,89) |
1 |
| Length of mechanical ventilation, days |
9,90 ± 10,28 |
7,19 ± 7,89 |
0,26 |
| Tracheostomy (%) |
30 (78,95) |
21(55,26) |
0,03 |
|
